European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting
EventHuman
Date
- - ,
Location
- European Medicines Agency, Amsterdam, the Netherlands
Event summary
This meeting brings together the members of the Patients' and Consumers' Working Party (PCWP) and the Healthcare Professionals' Working Party (HCPWP).
Documents
Agenda - European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting
Reference Number: EMA/567941/2023
English (EN) (269.41 KB - PDF)
First published: Last updated:
Meeting summary - Joint Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties meeting
Reference Number: EMA/79367/2024
English (EN) (298.28 KB - PDF)
First published:
Presentation - PCWP-HCPWP workplan 2022-2025 Mid-point implementation report - Ivana Silva
English (EN) (319.85 KB - PDF)
First published:
Presentation - Overview of 2022-2023 Stakeholder Engagement biennial report - Maria Filancia
English (EN) (403.86 KB - PDF)
First published:
Presentation - Revamp of the Human Medicines Highlights newsletter - Kaisa Immonen
English (EN) (752.19 KB - PDF)
First published:
Presentation - Third party interventions for WP - Fabrizio Boccacci
English (EN) (343.88 KB - PDF)
First published:
Presentation - Cancer Medicines as pathfinder - Francesco Pignatti
English (EN) (374.66 KB - PDF)
First published:
Presentation - Conversations on cancer - Caroline Voltz
English (EN) (1.37 MB - PDF)
First published:
Presentation - Patient experience data reflection paper - Rosa Gonzalez-Quevedo
English (EN) (1.14 MB - PDF)
First published:
Presentation - Patient experience data and therapeutic areas - Survey - Rosa Gonzalez-Quevedo
English (EN) (256.38 KB - PDF)
First published:
Presentation - Update on EU Network Training Centre - Esther Martinez
English (EN) (1004 KB - PDF)
First published:
Presentation - Preparation of amendments to EC Implementing Regulation 5202012 on the performance of pharmacovigilance activities - Izabela Taborska
English (EN) (258.88 KB - PDF)
First published:
Presentation - Risk minimisation for patient safety – update on policies and practices - Priya Bahri
English (EN) (347.95 KB - PDF)
First published:
Presentation - European Network of Paediatric Research at EMA - Gunter Egger
English (EN) (545.27 KB - PDF)
First published:
Presentation - PL improvement - Monica Buch
English (EN) (187.07 KB - PDF)
First published:
Presentation - Feedback from stakeholders of the subgroup - Courtney Davis
English (EN) (145.9 KB - PDF)
First published:
Presentation - Debriefing EMA workshop on Long COVID - Stephanie Buchhol
English (EN) (230.46 KB - PDF)
First published:
Presentation - Input Long COVID Europe on Long Covid Trials - Chantal Britt
English (EN) (281.41 KB - PDF)
First published:
Presentation - ACT EU update - Ana Zanoletty
English (EN) (941.7 KB - PDF)
First published:
Presentation - Data discoverability HMA-EMA Catalogues of Real-World Data sources and studies - Ana Cochino
English (EN) (1.66 MB - PDF)
First published:
Presentation - EU list of critical medicines_launch of Phase 2 - Joao Francisco Ferreira
English (EN) (554.32 KB - PDF)
First published:
Glucagon-like Peptide-1 (GLP1) Receptor Agonists - Klaus Kruttwig, Romana Micovcakova
English (EN) (444.76 KB - PDF)
First published: